Arvee Laboratories (India) Ltd
Company Profile
Business description
Arvee Laboratories (India) Ltd is a specialty chemical company. The company operates in two segments namely- bulk chemicals and specialty chemicals. Its products include Polymer Modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, and others, Contrast Media Intermediates such as Dimethyl 5-Aminoisophthalate, 3,5-Diamino Benzoic Acid, 5-Nitroisophthalic acid and others; and Drug Intermediates like 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde and others. Geographically, operations and revenue are concentrated within India markets expanding their exports in Asia- Pacific markets.
Contact
Iskcon Bopal Road
403, Entice Building
Opposite Jayantilal Park BRTS Bus Stop
Ambli
AhmedabadGJ380058
INDT: +91 2717430479
Sector
Basic Materials
Stock type
Cyclical
Industry
Specialty Chemicals
Fiscal Year End
31 March 2027
Employees
57
Stocks News & Analysis
stocks
Anthropic and OpenAI face commodification threats. Here’s what to watch for
stocks
Berkshire Hathaway: Abel pushes into new territory with Bending Spoons investment
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,975.70 | 35.30 | 0.39% |
| CAC 40 | 7,868.05 | 88.65 | -1.11% |
| DAX 40 | 25,319.77 | 302.84 | -1.18% |
| Dow JONES (US) | 51,989.87 | 12.54 | -0.02% |
| FTSE 100 | 10,764.69 | 117.21 | -1.08% |
| HKSE | 24,186.83 | 124.11 | 0.52% |
| NASDAQ | 26,477.03 | 337.00 | 1.29% |
| Nikkei 225 | 64,916.70 | 407.59 | -0.62% |
| NZX 50 Index | 13,652.07 | 101.66 | -0.74% |
| S&P 500 | 7,700.97 | 41.53 | 0.54% |
| S&P/ASX 200 | 8,845.70 | 39.00 | 0.44% |
| SSE Composite Index | 3,716.28 | 8.81 | 0.24% |